Managing patients with new oral anticoagulants in perioperative period is not yet well protocolized. We report a clinical case of a critical haematuria after prostate biopsies to a patient treated with RIVAROXABAN. Monitoring and treatment of the haematuria have been difficult due to the lack of biological control and antidote for this treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.purol.2013.04.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!